Fingerprint
Dive into the research topics of 'Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
Shadi Chamseddine, Michael LaPelusa, Lianchun Xiao, Yehia I. Mohamed, Sunyoung S. Lee, Zishuo Ian Hu, Rikita I. Hatia, Manal Hassan, James C. Yao, Dan G. Duda, Saumil Datar, Hesham M. Amin, Ahmed O. Kaseb
Research output: Contribution to journal › Article › peer-review